Display of Native SARS-CoV-2 Spike on Mammalian Cells to Measure Antibody Affinity and ADCC
The COVID-19 pandemic led to the rapid development of antibody-based therapeutics and vaccines targeting the SARS-CoV-2 spike protein. Several antibodies have been instrumental in protecting vulnerable populations, but their utility was limited by the emergence of spike variants with diminished susc...
Saved in:
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Bio-protocol LLC
2024-11-01
|
Series: | Bio-Protocol |
Online Access: | https://bio-protocol.org/en/bpdetail?id=5119&type=0 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|